Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Faron Pharmaceuticals (FARN) Share Price

Price 41.50p on 25-06-2026 at 18:15:09
Change -2.00p -4.6%
Buy 42.00p
Sell 41.00p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Buy 25,000.00 at 41.60p
Day's Volume: 71,578
Last Close: 41.50p
Open: 42.00p
ISIN: FI4000153309
Day's Range 41.50p - 42.00p
52wk Range: 38.70p - 240.00p
Market Capitalisation: £84.20m
VWAP: 41.1042p
Shares in Issue: 202.88m

Sector: Medicine and Biotech

Listed In: FTSE AIM 100, FTSE AIM All-Share,

Faron Pharmaceuticals (FARN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 25,000 41.60p Ordinary
 16:40:00 - 25-Jun-26
Sell* 2,714 41.0501p Ordinary
 15:49:34 - 25-Jun-26
Sell* 1,282 41.00p Ordinary
 15:00:52 - 25-Jun-26
Buy* 750 42.00p Ordinary
 14:59:49 - 25-Jun-26
Sell* 17,655 41.02p Ordinary
 14:58:08 - 25-Jun-26
Sell* 3 41.00p SI Trade
 14:31:39 - 25-Jun-26
Buy* 314 41.99p Ordinary
 11:35:21 - 25-Jun-26
Sell* 14,734 40.25p Negotiated Trade
 11:29:32 - 25-Jun-26
Sell* 7,085 41.22p Ordinary
 10:36:58 - 25-Jun-26
Sell* 41 41.00p SI Trade
 09:14:03 - 25-Jun-26
See more Faron Pharmaceuticals trades

Faron Pharmaceuticals (FARN) Share Price History

Time period:
to
Date Open High Low Close Volume
25th Jun 2026 (Thu) 42.00 42.00 41.50 41.50 71,578
24th Jun 2026 (Wed) 43.50 43.50 43.50 43.50 3,869
23rd Jun 2026 (Tue) 44.00 45.00 43.50 43.50 30,339
22nd Jun 2026 (Mon) 43.50 44.50 43.50 44.00 15,160
19th Jun 2026 (Fri) 43.50 43.50 43.50 43.50 3,731
18th Jun 2026 (Thu) 42.50 44.50 42.60 43.50 201,046
17th Jun 2026 (Wed) 42.50 42.50 40.60 42.50 56,567
16th Jun 2026 (Tue) 45.00 42.00 42.00 42.00 198,831
15th Jun 2026 (Mon) 45.00 45.50 42.80 45.00 231,618
12th Jun 2026 (Fri) 43.50 45.00 43.50 45.00 17,943
11th Jun 2026 (Thu) 43.50 43.50 43.50 43.50 6,141
10th Jun 2026 (Wed) 43.50 43.50 43.50 43.50 43,256
9th Jun 2026 (Tue) 45.00 45.00 43.50 43.50 18,659
8th Jun 2026 (Mon) 46.00 46.00 43.50 45.00 73,845
5th Jun 2026 (Fri) 46.00 46.00 45.50 46.00 88,245
4th Jun 2026 (Thu) 46.00 47.40 47.40 47.40 48,529
3rd Jun 2026 (Wed) 46.00 46.00 46.00 46.00 7,839
2nd Jun 2026 (Tue) 46.00 46.00 46.00 46.00 49,113
1st Jun 2026 (Mon) 47.00 47.00 46.00 46.00 115,784
29th May 2026 (Fri) 46.50 47.00 46.50 47.00 72,556
28th May 2026 (Thu) 46.50 48.50 46.50 47.00 119,352
27th May 2026 (Wed) 45.00 46.50 46.00 46.50 153,474
26th May 2026 (Tue) 41.50 46.00 41.50 45.00 148,551
See more Faron Pharmaceuticals price history

Faron Pharmaceuticals (FARN) Regulatory News

Date Source Headline
22nd Jun 2026 2:00 pm MFN Faron Pharmaceuticals: FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY
17th Jun 2026 2:30 pm MFN Faron Pharmaceuticals: FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY
17th Jun 2026 7:00 am MFN Faron Pharmaceuticals: FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY
15th Jun 2026 4:00 pm MFN Faron Pharmaceuticals: FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY
11th Jun 2026 3:05 pm MFN Faron Pharmaceuticals: FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY
11th Jun 2026 3:00 pm MFN Faron Pharmaceuticals: Faron Pharmaceuticals Ltd: Registration of Treasury Shares
10th Jun 2026 5:45 pm MFN Faron Pharmaceuticals: FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY
8th Jun 2026 5:30 pm MFN Faron Pharmaceuticals: FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY
5th Jun 2026 11:50 am MFN Faron Pharmaceuticals: Faron Pharmaceuticals Receives Decision from Nasdaq Helsinki Disciplinary Committee
4th Jun 2026 1:00 pm MFN Faron Pharmaceuticals: FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY
See more Faron Pharmaceuticals regulatory news

Faron Pharmaceuticals (FARN) Share News

IN BRIEF: Faron Pharmaceuticals fined EUR30,000 by Nasdaq Helsinki

5th Jun 2026 12:37

Faron Pharmaceuticals Ltd - Turku, Finland-based cancer drug developer - Says the Disciplinary Committee of Nasdaq Helsinki Ltd has imposed an EUR30,000 fine over breaches in 2024. The committee found that Faron breached the Nasdaq First North Growth Rulebook for Issuers of Shares, regarding "the obligation to disclose inside information without undue delay in certain matters". It also breached "good securities market practise" regarding "certain public statements made in a media interview". Faron notes that the committee dismissed two alleged breaches, including "importantly," the allegation that Faron had not organised its administration in the manner required for listed companies. Read More

UK shareholder meetings calendar - next 7 days

27th Apr 2026 12:17

Read More

WINNERS & LOSERS: James Cropper sees earnings up; Block sells stake

14th Apr 2026 11:37

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday. Read More

WINNERS & LOSERS: Secure Trust holds provision; Steppe sales rise

10th Apr 2026 10:11

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Friday. Read More

IN BRIEF: Faron Pharmaceuticals hires Heikki Jouttijarvi as CTO

27th Mar 2026 07:00

Faron Pharmaceuticals Ltd - Turku, Finland-based cancer drug developer - Hires Heikki Jouttijarvi as chief technical officer, saying he has decades of experience in biopharma manufacturing, supply chain management and commercial operations. Chief Executive Officer Juho Jalkanen says: "His wealth of experience with commercial operations, manufacturing and supply chain management with late-stage and approved drugs is incredibly valuable for us as we progress with bexmarilimab to the announced phase IIb trial in higher-risk myelodysplastic syndromes". Bexmarilimab is an investigational immunotherapy designed to overcome resistance to existing treatments, among others. Myelodysplastic syndromes are a type of blood cancer. Read More

See more Faron Pharmaceuticals news
FTSE 100 Latest
Value10,529.89
Change68.26

Login to your account

Forgot Password?

Not Registered